Skip to main content
Tech.euFundingExplorerBeta

FineHeart

A clinical-stage medical technology company developing FlowMaker, an intracardiac pump for the treatment of advanced heart failure.

FineHeart has raised €110M across 4 funding rounds from 14 investors, most recently a Grant round in Jan 2026. Based in Pessac, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€110M
€110,410,000
Funding rounds
4
Investors
14
distinct backers
Active since
2016-03
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
FineHeart — funding by year — interactive chart.
Data table
FineHeart — funding by year
2016€6.4M
2021€21M
2026€83M

Signals

High confidence
Raise-next likelihood71
base rate 45% for Grant
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 4 rounds raised
  • ▲ 10y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds

Similar companies

same sector or country

Global coverage: FundingData